10 Recruiting IgA Nephropathy Clinical Trials
Explore open interventional and observational research studies actively enrolling participants across the USA. Verify eligibility and contact site coordinators directly.
📍 Find Near Me by DistanceBrowse by State
Browse by Study Phase
Top Interventions for IgA Nephropathy
Related Conditions
Top Recruiting IgA Nephropathy Studies
🔵 Active, Not Recruiting Phase3 💊 Investigational Drug / Biologic
A Study of Zigakibart in Adults With IgA Nephropathy
📍 University of Alabama at Birmingham: The Kirklin Clinic — Birmingham, Alabama
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase3 💊 Investigational Drug / Biologic
Atrasentan in Patients With IgA Nephropathy
📍 University of Alabama at Birmingham — Birmingham, Alabama
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase2 💊 Investigational Drug / Biologic
Atrasentan in Patients With Proteinuric Glomerular Diseases
📍 Kidney Disease Medical Group — Glendale, California
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase3 💊 Investigational Drug / Biologic
Atacicept in Subjects With IgA Nephropathy
📍 ORIGIN 3 Global Site Contact Information — Brisbane, California
View Study & Checklist ➔ 🟢 Recruiting Phase2 💊 Investigational Drug / Biologic
A Phase 2 Study to Evaluate the Safety, PD, PK, and Clinical Activity of ADX-097 in Participants With IgAN, LN or C3G
📍 Investigator Site #1 — Lawrenceville, Georgia
View Study & Checklist ➔ 🟢 Recruiting Phase1 💊 Investigational Drug / Biologic
Study of BHV-1400 in IgA Nephropathy
📍 Site-001 — Farmington, Connecticut
View Study & Checklist ➔ 🟢 Recruiting Phase2 💊 Investigational Drug / Biologic
Trial of the Impact of Sibeprenlimab on Immunoglobulin A Nephropathy Kidney Tissue
📍 Clinical Research Site 330 — Denver, Colorado
View Study & Checklist ➔ 🟢 Recruiting Phase2 💊 Investigational Drug / Biologic
A Study of JADE101 in Participants With Immunoglobulin A Nephropathy
📍 Jade Clinical Site — Chula Vista, California
View Study & Checklist ➔ 🟢 Recruiting Phase4 💊 Investigational Drug / Biologic
Efficacy and Safety of Extended TARPEYO® Treatment Beyond 9 Months in Adult Patients With Primary IgA Nephropathy
📍 Univ of Alabama/Birmingham — Birmingham, Alabama
View Study & Checklist ➔